A Phase 1, Double Blind, Sponsor Open, Placebo Controlled Combined Single And Multiple Ascending Dose Study To Investigate The Safety, Tolerability And Food Effect On Pharmacokinetics Of PF-06669571 Following Oral Doses In Healthy Subjects

Trial Profile

A Phase 1, Double Blind, Sponsor Open, Placebo Controlled Combined Single And Multiple Ascending Dose Study To Investigate The Safety, Tolerability And Food Effect On Pharmacokinetics Of PF-06669571 Following Oral Doses In Healthy Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 21 Apr 2015

At a glance

  • Drugs PF 6669571 (Primary)
  • Indications Parkinson's disease
  • Focus Adverse reactions
  • Sponsors Pfizer
  • Most Recent Events

    • 16 Apr 2015 Status changed from recruiting to completed, according to to ClinicalTrials.gov record.
    • 26 Sep 2014 According to the ClinicalTrials.gov record, planned end date changed from 1 Mar 2015 to 1 Apr 2015.
    • 01 Aug 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top